×
About 4,853 results

ALLMedicine™ Thyroglobulin Center

Research & Reviews  2,399 results

Impact of levothyroxine in women with positive thyroid antibodies on pregnancy outcomes...
https://doi.org/10.1136/bmjopen-2020-043751
BMJ Open; Lau L, Benham JL et. al.

Feb 24th, 2021 - To evaluate the effect of levothyroxine therapy on pregnancy outcomes compared with placebo or no treatment in women without overt hypothyroidism with presence of thyroid peroxidase antibodies (TPOAb) and/or thyroglobulin antibodies (TgAb). System...

Diagnosis of sarcoidosis in a patient with differentiated thyroid cancer and sudden ris...
https://doi.org/10.1007/s12020-021-02613-4 10.1038/s41572-019-0096-x 10.1530/eje.0.1340331 10.1046/j.1365-2265.1997.1630976.x 10.1016/j.autrev.2016.09.009
Endocrine Vanessa F, Frediano I et. al.

Feb 18th, 2021 - Diagnosis of sarcoidosis in a patient with differentiated thyroid cancer and sudden rise of anti-thyroglobulin antibodies during follow-up.|2021|Vanessa F,Frediano I,Luca Z,|

"False positives in thyroglobulin determinations due to the presence of heterophile ant...
https://doi.org/10.1016/j.eprac.2020.10.011
Endocrine Practice : Official Journal of the American Col... Barbesino G, Algeciras-Schimnich A et. al.

Feb 13th, 2021 - Thyroglobulin measurement is essential in thyroid cancer management. Immunometric assays are widely utilized for thyroglobulin measurement; however, heterophilic antibodies can cause falsely elevated thyroglobulin determinations. This problem is u...

A double mutation of BRAF L597Q and V600E in situ and solitary brain metastasis of occu...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886408
Medicine Chen L, Wu Y et. al.

Feb 13th, 2021 - The rare BRAF L597Q (c.T1790A) point mutation has been previously reported in childhood acute lymphoblastic leukemia. We present the first rare case of occult papillary thyroid carcinoma with BRAF L597Q mutation in a Tibetan patient. A 57-year-old...

see more →

Drugs  2 results see all →

Clinicaltrials.gov  2,423 results

Impact of levothyroxine in women with positive thyroid antibodies on pregnancy outcomes...
https://doi.org/10.1136/bmjopen-2020-043751
BMJ Open; Lau L, Benham JL et. al.

Feb 24th, 2021 - To evaluate the effect of levothyroxine therapy on pregnancy outcomes compared with placebo or no treatment in women without overt hypothyroidism with presence of thyroid peroxidase antibodies (TPOAb) and/or thyroglobulin antibodies (TgAb). System...

Diagnosis of sarcoidosis in a patient with differentiated thyroid cancer and sudden ris...
https://doi.org/10.1007/s12020-021-02613-4 10.1038/s41572-019-0096-x 10.1530/eje.0.1340331 10.1046/j.1365-2265.1997.1630976.x 10.1016/j.autrev.2016.09.009
Endocrine Vanessa F, Frediano I et. al.

Feb 18th, 2021 - Diagnosis of sarcoidosis in a patient with differentiated thyroid cancer and sudden rise of anti-thyroglobulin antibodies during follow-up.|2021|Vanessa F,Frediano I,Luca Z,|

"False positives in thyroglobulin determinations due to the presence of heterophile ant...
https://doi.org/10.1016/j.eprac.2020.10.011
Endocrine Practice : Official Journal of the American Col... Barbesino G, Algeciras-Schimnich A et. al.

Feb 13th, 2021 - Thyroglobulin measurement is essential in thyroid cancer management. Immunometric assays are widely utilized for thyroglobulin measurement; however, heterophilic antibodies can cause falsely elevated thyroglobulin determinations. This problem is u...

A double mutation of BRAF L597Q and V600E in situ and solitary brain metastasis of occu...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886408
Medicine Chen L, Wu Y et. al.

Feb 13th, 2021 - The rare BRAF L597Q (c.T1790A) point mutation has been previously reported in childhood acute lymphoblastic leukemia. We present the first rare case of occult papillary thyroid carcinoma with BRAF L597Q mutation in a Tibetan patient. A 57-year-old...

see more →

News  29 results

Subclinical Hypothyroidism Balancing Act: Knowing When to Treat
https://www.staging.medscape.com/viewarticle/919024_4

Oct 2nd, 2019 - Question: What should you do next? Your Peers Chose: Start levothyroxine 0% Repeat TSH test in 2-3 months and check TPO antibody level 0% Reassure the patient that no treatment is needed; repeat TSH test in 1 year 0% Check thyroglobulin and thyrog...

When it comes to thyroid cancer follow-up, serum microRNA profiles have earned new respect
https://www.mdedge.com/familymedicine/article/161165/pituitary-thyroid-adrenal-disorders/when-it-comes-thyroid-cancer/page/0/1
Clinical Endocrinology News;

Mar 18th, 2018 - Serum levels of both miRNAs after 1 to 2 years of follow-up were consistent with ATA responses to therapy in all patients, including two patients who developed structural evidence of disease whose thyroglobulin assay results remained negative (les.

Thyroid-nodule size boosts serum thyroglobulin’s diagnostic value
https://www.mdedge.com/familymedicine/article/143633/pituitary-thyroid-adrenal-disorders/thyroid-nodule-size-boosts-serum
Clinical Endocrinology News; Mitchel L. Zoler

Jul 31st, 2017 - BOSTON – Normalizing the serum thyroglobulin level by thyroid nodule size in patients surgically treated for a thyroid nodule produced a strongly significant link between the level of this marker and nodule malignancy in a review of nearly 200 pat.

Thyroid Cancer: Incidence on the Rise
https://www.mdedge.com/clinicianreviews/article/114971/endocrinology/thyroid-cancer-incidence-rise/page/0/3

Oct 11th, 2016 - LONG-TERM PATIENT MANAGEMENT After thyroidectomy and radioactive iodine treatment, follicular cell cancers (eg, papillary, follicular, anaplastic) are managed by following patients’ thyroid-stimulating hormone (TSH), thyroglobulin, and antithyrogl.

Thyroglobulin can’t predict pazopanib response in differentiated thyroid cancer
https://www.mdedge.com/internalmedicine/article/103709/head-neck-cancers/thyroglobulin-cant-predict-pazopanib-response
Michele G. Sullivan

Oct 21st, 2015 - Lake BUENA VISTA, FLA. – Pazopanib is an effective therapy for advanced thyroid cancer, but at present, there seems to be no way to predict which patients will respond to it.

see more →